Well-Being Therapy by Personalized Mobile Technology Program for Psychological Distress and Promote Healthy Behaviors

Overview

The WELL-ME study is a three-arm randomized controlled clinical trial (RCT). The aim of this RCT is to compare the effectiveness of the Well Being Web Based Therapy (WBT-Web) with the gold standard CBT (Cognitive Behavior Therapy) and standard clinical procedure of patients' management (CM) for psychological distress and promotion of healthy behaviors in Cardiac Patients.

Full Title of Study: “Well-Being Therapy for Psychological Distress and Enhancing Healthy Behaviors With Personalized Mobile Technology in Cardiac Patients: a Randomized Controlled-trial Study Protocol”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: February 2009

Detailed Description

Cardiac disease (CD) affects millions of European and Americans and new diagnosis rates are expected to almost triple over the next 30 years as our population ages. Affective disorders including clinical depression, anxiety and psychological distress are common in patients with CD. Furthermore, the presence of these disorders significantly impacts quality of life, adherence to medical prescription and healthy behaviors. The prevalence of depression, ranging from 11% to 25% among heart disease outpatients and 35% to 70% among those who are hospitalized. Psychological depression appears to be an important predictor of rehospitalization among persons who have been admitted with coronary artery disease. In addition, depression in patients with heart failure was found to be associated with the course of the disease and its prognosis. The high prevalence of psychological distress among the population of patients with heart failure, along with the broad impact on the patient's quality of life, requires attention to detail and the implementation of interventions aimed at reducing levels of distress. Very few studies describe interventions aimed at alleviating distress in patients with heart failure. Cognitive Behavioral Therapy (CBT) is reported to improve both the functional and emotional levels of these patients, resulting in the relief of their symptoms of depression. Recently Well Being Therapy WBT) have showed promising outcomes findings for depression and distress. There is a need to treat patients in their real life setting. Recent technological innovations in the ICT provide to monitor and treat the patient at a distance outside the hospital. The aim in this study is to study the effectiveness of the WBT-WEB in reducing psychological distress, and improving QoL, healthy behaviors and medical adherence in HR compared to a CBT and standard clinical procedure of patients' management (CM). The same protocol will be carried out in two centres (Hospital de Terrassa, Barcelona, Spain; National and Kapodistrian University of Athens, Greece). 300 patients diagnosed with cardiac disease, and with psychological distress, assessed by Hospital Anxiety and Depression Scale (HADS) will be randomized to one of three treatment groups: 1) WBT-WEB; 2) CBT and 3) CM. A one-year follow-up will be performed. It is expected that WBT-WEB may significantly decrease psychological distress and increase QoL, healthy behaviors and medical adherence at follow-up compared to clinical management.

Interventions

  • Behavioral: Well-Being Therapy based on Web Mobile Technology
    • The techniques included in WBT may be used in overcoming impairments in environmental mastery, purpose in life, personal growth, autonomy, self-acceptance and positive relations with others.
  • Behavioral: Cognitive Behavior Therapy
    • CBT involves several essential features: identifying and correcting inaccurate thoughts associated with depressed feelings (cognitive restructuring); helping patients to engage more often in enjoyable activities (behavioral activation); enhancing problem-solving skills; providing instruction and guidance in specific strategies for solving problems.
  • Other: Standardized Care Management
    • CM will consist of reviewing the patients’ clinical status, and providing the patient with support and advice if necessary.

Arms, Groups and Cohorts

  • Experimental: WBT-WEB
    • Well-Being Therapy based on Web Mobile technology
  • Active Comparator: CBT
    • Cognitive Behavior Therapy
  • No Intervention: CM
    • Standardized Care Management

Clinical Trial Outcome Measures

Primary Measures

  • Psychological distress
    • Time Frame: Within one year after the treatment
    • Depression, Anxiety, and well-being improvements (Psychological Distress Reduction)

Secondary Measures

  • Quality of Life
    • Time Frame: Within one year after the treatment
    • Quality of Life
  • Medical Adherence
    • Time Frame: Within one year after the treatment
  • Promotion of Healthy Lifestyle
    • Time Frame: Within one year after the treatment
    • Promotion of Healthy Lifestyle

Participating in This Clinical Trial

Inclusion Criteria

  • Cardiac Diseases – a current diagnosis of at least one of the following: major or minor depression, dysthymia, anxiety according, to DSM-IV criteria, and HADS criteria – Mini-Mental State Examination score higher than 24 – written informed consent provided by the patient to participate Exclusion Criteria:

  • uncertain prognosis for 12 months due to other conditions – acute coronary disease in recent months. – existence of another life-threatening illness of the patient (such as active cancer, chronic kidney failure). – severe neurological problem (Brain syndrome / orientation problem/ difficult peripheral neuropathy). – severe mental illness (active psychosis / suicide risk / severe dementia). – linguistic limitations (such as stuttering / untreated audio impairment). – a significant functional problem (such as unconsciousness / connection to respiration device / confined to a wheelchair or bed / severe walking disability / needs help with complete basic daily activities). – objective limit that endangers liability for participation in the seven meetings (such as remote residential / tourist / convict / drug addict).

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Bergamo
  • Provider of Information About this Clinical Study
    • Principal Investigator: Angelo Compare, Prof. – University of Bergamo
  • Overall Official(s)
    • Angelo Compare, Ph.D, Principal Investigator, University of Bergamo

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.